Literature DB >> 23271482

Hypertension-misattributed kidney disease in African Americans.

Karl L Skorecki1, Walter G Wasser.   

Abstract

Lipkowitz et al. extend the African American Study of Kidney Disease and Hypertension to the level of genetic epidemiology, in a case-control study design. Analysis of genotypes at the APOL1 kidney disease risk region supports a paradigm shift in which genetic risk is proximate to both kidney disease and hypertension. The findings mandate urgency in clarifying mechanisms whereby APOL1 region risk variants interact with environmental triggers to cause progressive kidney disease accompanied by dangerous hypertension.

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23271482     DOI： 10.1038/ki.2012.369

Source DB:  PubMed          Journal:  Kidney Int        ISSN： 0085-2538            Impact factor:   10.612


  21 in total

Review 1.  The Impact of APOL1 on Chronic Kidney Disease and Hypertension.

Authors:  Todd W Robinson; Barry I Freedman
Journal:  Adv Chronic Kidney Dis       Date:  2019-03       Impact factor: 3.620

2.  Editorial commentary: Risks and benefits of tenofovir in the context of kidney dysfunction in sub-Saharan Africa.

Authors:  Michelle M Estrella; Mohammed R Moosa; Jean B Nachega
Journal:  Clin Infect Dis       Date:  2014-02-27       Impact factor: 9.079

3.  APOL1 renal-risk genotypes associate with longer hemodialysis survival in prevalent nondiabetic African American patients with end-stage renal disease.

Authors:  Lijun Ma; Carl D Langefeld; Mary E Comeau; Jason A Bonomo; Michael V Rocco; John M Burkart; Jasmin Divers; Nicholette D Palmer; Pamela J Hicks; Donald W Bowden; Janice P Lea; Jenna O Krisher; Margo J Clay; Barry I Freedman
Journal:  Kidney Int       Date:  2016-05-06       Impact factor: 10.612

Review 4.  Diabetic Microvascular Disease: An Endocrine Society Scientific Statement.

Authors:  Eugene J Barrett; Zhenqi Liu; Mogher Khamaisi; George L King; Ronald Klein; Barbara E K Klein; Timothy M Hughes; Suzanne Craft; Barry I Freedman; Donald W Bowden; Aaron I Vinik; Carolina M Casellini
Journal:  J Clin Endocrinol Metab       Date:  2017-12-01       Impact factor: 5.958

Review 5.  Gene-gene and gene-environment interactions in apolipoprotein L1 gene-associated nephropathy.

Authors:  Barry I Freedman; Karl Skorecki
Journal:  Clin J Am Soc Nephrol       Date:  2014-06-05       Impact factor: 8.237

6.  Human Heredity and Health (H3) in Africa Kidney Disease Research Network: A Focus on Methods in Sub-Saharan Africa.

Authors:  Charlotte Osafo; Yemi Raheem Raji; David Burke; Bamidele O Tayo; Nicki Tiffin; Marva M Moxey-Mims; Rebekah S Rasooly; Paul L Kimmel; Akinlolu Ojo; Dwomoa Adu; Rulan S Parekh
Journal:  Clin J Am Soc Nephrol       Date:  2015-07-02       Impact factor: 8.237

Review 7.  Genetics in kidney disease in 2013: Susceptibility genes for renal and urological disorders.

Authors:  Jasmin Divers; Barry I Freedman
Journal:  Nat Rev Nephrol       Date:  2013-12-03       Impact factor: 28.314

8.  JC polyoma virus interacts with APOL1 in African Americans with nondiabetic nephropathy.

Authors:  Jasmin Divers; Marina Núñez; Kevin P High; Mariana Murea; Michael V Rocco; Lijun Ma; Donald W Bowden; Pamela J Hicks; Mitzie Spainhour; David A Ornelles; Steven B Kleiboeker; Kara Duncan; Carl D Langefeld; Jolyn Turner; Barry I Freedman
Journal:  Kidney Int       Date:  2013-05-15       Impact factor: 10.612

Review 9.  Rethinking hypertensive kidney disease: arterionephrosclerosis as a genetic, metabolic, and inflammatory disorder.

Authors:  Jeffrey B Kopp
Journal:  Curr Opin Nephrol Hypertens       Date:  2013-05       Impact factor: 2.894

10.  Histopathologic findings associated with APOL1 risk variants in chronic kidney disease.

Authors:  Christopher P Larsen; Marjorie L Beggs; Mohammad Saeed; Josephine M Ambruzs; L Nicholas Cossey; Nidia C Messias; Patrick D Walker; Barry I Freedman
Journal:  Mod Pathol       Date:  2014-08-01       Impact factor: 7.842
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.